Roberts William T. 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Mar 31, 2023
Insider Transaction Report
Form 4
Roberts William T.
Chief Accounting Officer
Transactions
- Sale
Common Stock
2023-03-29$17.50/sh−912$15,960→ 7,872 total - Exercise/Conversion
Restricted Stock Units
2023-03-29−2,500→ 5,000 total→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2023-03-29+2,500→ 8,784 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The restricted stock units vest or have vested as to 50% of the shares on each of March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date.